For example, the level of phosphorylated cofilin was found to be decreased by the Aβ treatment as well as in the brain of AD mouse models [25, 28–38], suggesting that overactivation of cofilin may contribute to AD pathology. The gene discussed is CFL1; the disease is Alzheimer disease.